Literature DB >> 33874991

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.

Alice Annalisa Medaglia1,2, Lucia Siracusa3, Claudia Gioè4,3, Salvatore Giordano3, Antonio Cascio4, Claudia Colomba4.   

Abstract

Kawasaki disease (KD) is a vasculitis of unknown origin of small and medium caliber blood vessels, especially involving coronary arteries and is the leading cause of acquired heart disease in childhood in developed countries. Although rarely, it can recur: most recurrences occur within 2 years of the initial episode. No data are available on incidence of recurrent KD in Europe and multiple recurrences are rarely seen. We reviewed the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection. We believe that in our case SARS Cov2 acted as a trigger capable to determine, in a genetically susceptible individual, a second recurrence of the disease. In the Covid-19 era we affirm the importance for Kawasaki disease to be tested for SARS Cov2 infection.

Entities:  

Keywords:  Covid-19; Kawasaki disease recurrence; Recurrent Kawasaki disease; Sars-Cov2

Year:  2021        PMID: 33874991     DOI: 10.1186/s13052-021-01041-4

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  22 in total

1.  Recurrent Kawasaki disease.

Authors:  S Balasubramanian; R Ganesh
Journal:  Indian J Pediatr       Date:  2009-05-27       Impact factor: 1.967

2.  Recurrent Kawasaki disease.

Authors:  Pramila Verma; Neeti Agarwal; Mahesh Maheshwari
Journal:  Indian Pediatr       Date:  2015-02       Impact factor: 1.411

3.  Recurrent Kawasaki Disease.

Authors:  Arpan Saha; Sumantra Sarkar
Journal:  Indian J Pediatr       Date:  2017-12-14       Impact factor: 1.967

4.  Recurrent Kawasaki disease associated with co-infection with parvovirus B19 and HIV-1.

Authors:  G Nigro; P Pisano; A Krzysztofiak
Journal:  AIDS       Date:  1993-02       Impact factor: 4.177

5.  Exposure of drivers to carbon monoxide.

Authors:  D M Colwill; A J Hickman
Journal:  J Air Pollut Control Assoc       Date:  1980-12

Review 6.  Recurrent Kawasaki disease.

Authors:  M N Pemberton; I M Doughty; R J Middlehurst; M H Thornhill
Journal:  Br Dent J       Date:  1999-03-27       Impact factor: 1.626

7.  Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience.

Authors:  Sandesh Guleria; Rakesh Kumar Pilania; Ankur Kumar Jindal; Dharmagat Bhattarai; Deepti Suri; Surjit Singh
Journal:  Int J Rheum Dis       Date:  2019-03-03       Impact factor: 2.454

Review 8.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

9.  A sibship with recurrent Kawasaki disease and coronary artery lesion.

Authors:  T Matsubara; S Furukawa; T Ino; A Tsuji; I Park; K Yabuta
Journal:  Acta Paediatr       Date:  1994-09       Impact factor: 2.299

10.  COVID-19 and Kawasaki disease in children.

Authors:  Suowen Xu; Mingwu Chen; Jianping Weng
Journal:  Pharmacol Res       Date:  2020-05-25       Impact factor: 7.658

View more
  4 in total

1.  Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children.

Authors:  Emilie P Buddingh; Ann C T M Vossen; Hildo J Lamb; Roel L F van der Palen; Danielle M C Brinkman
Journal:  Pediatr Infect Dis J       Date:  2021-12-01       Impact factor: 3.806

Review 2.  A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children.

Authors:  Philip A Wessels; Michael A Bingler
Journal:  Prog Pediatr Cardiol       Date:  2022-03-16

Review 3.  Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.

Authors:  Carlo Alberto Maronese; Enrico Zelin; Gianluca Avallone; Chiara Moltrasio; Maurizio Romagnuolo; Simone Ribero; Pietro Quaglino; Angelo Valerio Marzano
Journal:  Front Med (Lausanne)       Date:  2022-08-23

Review 4.  The year 2021 in COVID-19 pandemic in children.

Authors:  Elena Bozzola; Carlo Caffarelli; Francesca Santamaria; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2022-09-05       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.